Jason Kopcak: That’s great, Matt. That’s a great question. That’s been a focus of ours. When we tested our, our proprietary lead generation in late Q3 and Q4 last year, we realized that we could ramp pretty easily. So it became paramount to add these forward flows. So with that being said, we’re currently signed up with three passes four takeout partners. Three of the four partners have pockets of money for life, life insurance. We’re in addition, we’re talking probably another six to eight, I would say, three quarters of those are life companies, and another three to five money managers. On the insurance side, it can’t get enough products. It just, we could originate 300 million a month, and it — we couldn’t sell the buckets.
So there’s massive amounts of capital, they’re under pressure to figure out different ways to deploy their capital into above market rates, getting away from the liquid agency market. And so there’s tremendous amount of capital being raised in insurance companies. We see it, like, it’s not a matter of, do they have enough balance sheet, they can’t get that product. So it but it’s a long process, when you sign up with insurance companies, they just don’t sign up with anybody, they pick a handful of partners, and they work with those people because, they don’t have the same infrastructure, they need to have a credible Counterparty, they need somebody who has the infrastructure has the resources to deliver quality products. And with us having a long history, with our team in India with our management team here, we are a pretty solid model for, for these light codes to partner with.
And so with that being said, we found that at the beginning a year, the life course have a ton of capital, and the money managers are some of their voice and some that are sitting on the sidelines, so with the money managers.
Matthew Howlett: Did you think you’re almost up to almost 10 counterparties? And would they have been what would the flow arrangements look like? I mean, were they would they, how big would they have been €“ did I hear you say you could, you could do 300 — I mean, you said, demand is just sensational. So can you just give us a sense how big each of them could be?
Jason Kopcak: So let me step back a second. So we’re in our standard with like a double check for sure. Three, if not four, counterparties. We’re in talks, another seven, eight, okay. On the term side DSCR products, we could originate just under a term product, we could originate 200 million, 300 million month, and I still wouldn’t be able to fill this the various insurance companies are talking to. So these insurance companies have a mandate to, and we’re talking to each one of them, I can’t even tell you, it’s going to be in the 10s of — it’s going to be like, I would assume they haven’t, they have a mandate to deploy 3 billion to 5 billion at least each in DSCR paper, if not more. And so with that being said about before, reaching 200 million a month, and that’s 2 billion, and we distribute that the three different groups, that 700 million per an insurance company, it’s a scratch in a bucket.